DIHEXA is changing the conversation around cognitive optimization., This is one of PA Tammy’s many, many favorite peptides! And for good reason 😉, Unlike options that can leave you feeling jittery or US$ 25.21 ★★★★★ 4.8 (22 reviews)
Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 23.26 ★★★★★ 4.3 (6 reviews)
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes US$ 29.05 ★★★★★ 4.0 (27 reviews)
Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial US$ 29.59 ★★★★★ 4.3 (14 reviews)
Cagrilintide–semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study US$ 29.09 ★★★★★ 4.1 (28 reviews)
New in the August 14, 2025, issue of NEJM: Cagrilintide–Semaglutide for Overweight or Obesity (REDEFINE 1 phase 3a trial) https://nej.md/444aW7f Cagrilintide–Semaglutide for Overweight and Diabetes (REDEFINE 2 phase 3a trial) https://nej.md/4ehQwLk US$ 29.41 ★★★★★ 4.4 (14 reviews)
New study comparing to weight loss drugs. Although one beat out the other by slim margin, a lot of people lost weight. What really matters is making these drugs affordable and available for those who US$ 23.83 ★★★★★ 5.0 (5 reviews)
Cagrilintide Weight Loss Results: What Patients in Louisiana Need to Know US$ 22.65 ★★★★★ 4.4 (20 reviews)
Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit US$ 24.31 ★★★★★ 4.1 (17 reviews)
CagrisSema is a once-weekly injection of semaglutide and cagrilintide. Phase 2 clinical trial results for CagriSema showed significant improvements in A1C, weight loss, and time in range, marking it as a promising US$ 29.56 ★★★★★ 4.8 (23 reviews)
Cagrilintide Peptide Dosing Guide: Titration, Schedule & Safety (2026) US$ 25.89 ★★★★★ 4.3 (21 reviews)
A new drug combo of semaglutide (GLP-1 receptor agonist) with cagrilintide (amylin analogue) failed to do as well as tirzepatide (GLP-1/GIP receptor agonist). The future of these medicines is hitting different receptors US$ 26.09 ★★★★★ 4.5 (20 reviews)
PDF] Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo- controlled and active-controlled, dose-finding phase 2 trial US$ 21.91 ★★★★★ 4.7 (21 reviews)
A unifying iron–dopamine–irisin/BDNF hypothesis for the Restless Legs Syndrome US$ 20.11 Min. order: 1 piece ★★★★★ 4.3 (15 reviews) Sold : Login>>
A Targeted Metabolomic Assessment of Oral Glutathione Bioavailability and Safety in Humans: A Randomized Crossover Clinical Trial US$ 27.63 Min. order: 1 piece ★★★★★ 4.7 (19 reviews) Sold : Login>>
Restless legs syndrome is a neurological disorder that causes an overwhelming urge to move the limbs and can negatively affect sleep and quality of life. Approximately 8% of US adults experience symptoms US$ 22.16 Min. order: 1 piece ★★★★★ 4.1 (12 reviews) Sold : Login>>
The Role of Glutathione Metabolism in Chronic Illness Development and Its Potential Use as a Novel Therapeutic Target US$ 28.58 Min. order: 1 piece ★★★★★ 4.5 (29 reviews) Sold : Login>>
Restless leg syndrome - DR STEVEN EDWARDS FACPS FELLOWSHIP TRAINED PODIATRIC SURGEON US$ 27.82 Min. order: 1 piece ★★★★★ 4.9 (12 reviews) Sold : Login>>
Glutathione S-Transferase mu 1/GSTM1 Antibody US$ 25.95 Min. order: 1 piece ★★★★★ 4.3 (9 reviews) Sold : Login>>
